← Back to Dashboard

Nelfinavir

HIV protease inhibitor · Inhibitor of lytic egress

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

CC1=C(C=CC=C1O)C(=O)NC(CSC2=CC=CC=C2)C(CN3CC4CCCCC4CC3C(=O)NC(C)(C)C)O
QAGYKUNXZHXKMR-HKWSIXNMSA-N

Clinical Development by Virus15

Human immunodeficiency virus 1
HIV-1
Target: Viral protease
FDA approved
Preclinical
Phase 2positive
Phase 3positive
Approved
FDAJapan
Human gammaherpesvirus 8
KSHV
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Human mastadenovirus B
HAdV-14
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Human mastadenovirus C
HAdV-1
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Human mastadenovirus C
HAdV-2
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Human mastadenovirus C
HAdV-5
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Human mastadenovirus C
HAdV-6
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Chikungunya virus
CHIKV
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Dengue virus
DENV-2
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Influenza A virus
FLUAV
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Hepacivirus C
HCV
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Human alphaherpesvirus 1
HSV-1
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan
Indiana vesiculovirus
VSV
Target: Unknown
Approved (other)
Preclinical
Phase 2
Phase 3
Approved
Japan